NSN 6505-01-510-2359 · NIIN 015102359 · FSC 6505
NO DASHES 6505015102359
In Stock
ISOSORBIDE MONONITRATE EXTENDED-
Drugs and Biologicals
Technical characteristics
11 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AJUC | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 241208 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS ISOSORBIDE MONONITRATE ACTIVE INGREDIENT 30.000 |
| AKJF | LONG ACTION METHOD | EXTENDED RELEASE |
| BLGJ | COATING FEATURE | FILM, NONENTERIC |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE, PLASTIC |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | TABLETS 100.000 |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 1 |
| CSGS | ADMINISTRATION | ORAL |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ISOSORBIDE MONONITRATE EXTENDED RELEASE TABS 30MG 100S |
| FEAT | SPECIAL FEATURES | EXTENDED RELEASE TABLETS, FOR THE PREVENTION OF ANGINA PECTORIS DUE TO CORONARY DISEASE; ONCE PER DAY DOSING; STORE AT ROOM TEMP.; PROTECT FROM EXCESSIVE MOISTURE |
| SUPP | SUPPLEMENTARY FEATURES | CARDIOVASCULAR USE |